TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis

Clinical trial NCT00228228 · UNKNOWN

Trial details

NCT number: NCT00228228
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2002-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.